SCHEMBL1807102

SCHEMBL1807102

CCOC(=O)c1c(C)n[nH]c1-c1c(F)cccc1COC

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE4D Q08499 1/20 0.47
NPC1 O15118 3/20 0.44
RAB9A P51151 2/20 0.44
KMT2A Q03164 2/20 0.44
SMN1; SMN2 Q16637 5/20 0.41
HTT P42858 1/20 0.41
MAPK10 P53779 1/20 0.41
CA12 O43570 1/20 0.40
CA1 P00915 1/20 0.40
CA2 P00918 1/20 0.40
CA7 P43166 1/20 0.40
CA9 Q16790 1/20 0.40
CA14 Q9ULX7 1/20 0.40
LMNA P02545 2/20 0.39
MAPT P10636 2/20 0.39
KDM4E B2RXH2 2/20 0.39
GAA P10253 2/20 0.39
ALDH1A1 P00352 1/20 0.39
HPGD P15428 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1806508 0.88 PDE4D (0.49) PDE4DNPC1RAB9AKMT2ASMN1; SMN2
SCHEMBL1805132 0.87 NPC1 (0.43) PDE4DNPC1RAB9AKMT2ASMN1; SMN2
SCHEMBL1804789 0.85 PDE4D (0.46) PDE4DNPC1RAB9AKMT2ASMN1; SMN2
SCHEMBL1805096 0.82 PDE4D (0.47) PDE4DNPC1RAB9AKMT2ASMN1; SMN2
SCHEMBL1809876 0.81 PDE4D (0.46) PDE4DNPC1RAB9AKMT2ASMN1; SMN2
SCHEMBL1806748 0.80 PDE4D (0.47) PDE4DNPC1RAB9ASMN1; SMN2HTT
SCHEMBL1806318 0.78 PDE4D (0.50) PDE4DNPC1RAB9AKMT2ASMN1; SMN2
SCHEMBL1808962 0.77 TTR (0.37) KMT2ASMN1; SMN2LMNAMAPTALDH1A1
SCHEMBL1806224 0.77 PDE4D (0.41) PDE4DNPC1RAB9AKMT2ASMN1; SMN2
SCHEMBL1808444 0.76 ALDH1A1 (0.36) KMT2AALDH1A1MEN1HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2501704-A1 SPIROPIPERIDINE COMPOUNDS AS ORL-1 RECEPTOR ANTAGONISTS Eli Lilly and Company (US) 2012-09-26 EP disclosed
WO-2011060217-A1 SPIROPIPERIDINE COMPOUNDS AS ORL-1 RECEPTOR ANTAGONISTS ELI LILLY AND COMPANY (US) 2011-05-19 WO disclosed